Cargando…

The effect of treatment package time in head and neck cancer patients treated with adjuvant radiotherapy and concurrent systemic therapy

OBJECTIVES: In patients with head and neck carcinoma, “treatment package time” (TPT) was proven to impact outcomes in cases receiving adjuvant radiotherapy alone. Its impact in patients receiving radiotherapy with concurrent systemic therapy has not been studied previously. The TPT influence on surv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghanem, Ahmed I., Schymick, Matthew, Bachiri, Souheyla, Mannari, Aniruddh, Sheqwara, Jawad, Burmeister, Charlotte, Chang, Steven, Ghanem, Tamer, Siddiqui, Farzan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	KeAi Publishing 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849356/ https://www.ncbi.nlm.nih.gov/pubmed/31750429 http://dx.doi.org/10.1016/j.wjorl.2018.09.005

Ejemplares similares

Cetuximab and anemia prevention in head and neck cancer patients undergoing radiotherapy
por: Maahs, Lucas, et al.
Publicado: (2022)

Galectins and Carcinogenesis: Their Role in Head and Neck Carcinomas and Thyroid Carcinomas
por: Kindt, Nadège, et al.
Publicado: (2017)

Concurrent radiotherapy and chemotherapy for locally advanced squamous cell carcinoma of the head and neck
por: Ali, Elsayed M, et al.
Publicado: (2011)

Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison
por: Soo, K-C, et al.
Publicado: (2005)

Evaluation of Neo-Adjuvant, Concurrent and Adjuvant Chemotherapy in the Treatment of Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
por: Akhlaghi, Fahimeh, et al.
Publicado: (2014)

Phase I study of oral S-1 and concurrent radiotherapy in patients with head and neck cancer
por: Nakata, Kensei, et al.
Publicado: (2013)

Unilateral Cervical Polyneuropathies following Concurrent Bortezomib, Cetuximab, and Radiotherapy for Head and Neck Cancer
por: Elghouche, Alhasan, et al.
Publicado: (2016)

Restoring p53 Function in Head and Neck Squamous Cell Carcinoma to Improve Treatments
por: de Bakker, Tycho, et al.
Publicado: (2022)

Systemic Effects of Radiotherapy and Concurrent Chemo-Radiotherapy in Head and Neck Cancer Patients—Comparison of Serum Metabolome Profiles
por: Jelonek, Karol, et al.
Publicado: (2020)

Adult-Onset Cerebral Adrenoleukodystrophy Without Adrenal Gland Involvement
por: Mannari, Aniruddh, et al.
Publicado: (2020)

Accelerated Radiotherapy with Concurrent Chemotherapy in Locally Advanced Head and Neck Cancers: Evaluation of Response and Compliance
por: Mashhour, Karim, et al.
Publicado: (2020)

Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer
por: Shirasu, Hiromichi, et al.
Publicado: (2020)

NRG-HN003: Phase I and Expansion Cohort Study of Adjuvant Pembrolizumab, Cisplatin and Radiation Therapy in Pathologically High-Risk Head and Neck Cancer
por: Bauman, Julie E., et al.
Publicado: (2021)

Adjuvant radiotherapy in high-risk cutaneous squamous cell cancer of the head and neck in immunosuppressed patients
por: Koyfman, Shlomo A., et al.
Publicado: (2015)

The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly
por: Haehl, Erik, et al.
Publicado: (2021)

Socioeconomic and Other Demographic Disparities Predicting Survival among Head and Neck Cancer Patients
por: Choi, Seung Hee, et al.
Publicado: (2016)

Adjuvant chemotherapy in head and neck cancer.
por: Stell, P. M., et al.
Publicado: (1990)

Head and neck INI1-deficient carcinoma without primary: a case report
por: Dubray-Vautrin, Antoine, et al.
Publicado: (2023)

The immunogenic radiation and new players in immunotherapy and targeted therapy for head and neck cancer
por: Sharon, Shay, et al.
Publicado: (2023)

Role of Concurrent Systemic Therapy with Adjuvant Radiation Therapy for Locally Advanced Cutaneous Head and Neck Squamous Cell Carcinoma
por: Goyal, Uma, et al.
Publicado: (2017)

Evaluation of the prognostic impact of postoperative adjuvant radiotherapy on head and neck mucosal melanoma: a meta-analysis
por: Li, Wei, et al.
Publicado: (2015)

Strategic Reduction of Package Time in Head and Neck Cancer
por: Duggar, William N., et al.
Publicado: (2022)

Outcomes of Post-Operative Treatment with Concurrent Chemoradiotherapy (CRT) in High-Risk Resected Oral Cavity Squamous Cell Carcinoma (OCSCC): A Multi-Institutional Collaboration
por: Babar, Arslan, et al.
Publicado: (2021)

Adaptive radiotherapy for head and neck cancer
por: Morgan, Howard E., et al.
Publicado: (2020)

Oral complications of radiotherapy in the head and neck
por: Jham, Bruno Correia, et al.
Publicado: (2015)

Proof-of-PUF Enabled Blockchain: Concurrent Data and Device Security for Internet-of-Energy
por: Asif, Rameez, et al.
Publicado: (2020)

Hyperfractionated Radiotherapy with Concurrent Cisplatin/5-Fluorouracil for Locoregional Advanced Head and Neck Cancer: Analysis of 105 Consecutive Patients
por: Zaboli, David, et al.
Publicado: (2012)

Concurrent Radiotherapy with Carboplatin and Cetuximab for the Treatment of Medically Compromised Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
por: Saigal, Kunal, et al.
Publicado: (2014)

Randomized phase III trial of concurrent chemoradiotherapy vs accelerated hyperfractionation radiotherapy in locally advanced head and neck cancer
por: Chitapanarux, Imjai, et al.
Publicado: (2013)

Concurrent cisplatin or cetuximab with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma: A meta-analysis
por: Tang, Wen-Hua, et al.
Publicado: (2020)

Assessment of Acute Side Effects Among 3D-Concurrent Radiotherapy With Cisplatin-Treated Head and Neck Cancer Patients
por: Mehmood, Hina, et al.
Publicado: (2023)

Effect of definitive hypo-fractionated radiotherapy concurrent with weekly cisplatin in locally advanced squamous cell carcinoma of the head and neck
por: Abdelhafiz, Nora, et al.
Publicado: (2023)

Accelerated vs. conventionally fractionated adjuvant radiotherapy in high-risk head and neck cancer: a meta-analysis
por: Matuschek, Christiane, et al.
Publicado: (2018)

A Comparative Prospective Study Between Conventional Chemo-Radiotherapy and Pure Accelerated Radiotherapy With Concurrent Chemotherapy for the Treatment of Locally Advanced Head and Neck Cancer
por: Das, Sumana M, et al.
Publicado: (2023)

Osteocutaneous flaps for head and neck reconstruction: A focused evaluation of donor site morbidity and patient reported outcome measures in different reconstruction options
por: Kearns, Marie, et al.
Publicado: (2018)

Outcomes of Primary Mucosal Head and Neck Squamous Cell Carcinoma in Solid Organ Transplant Recipients
por: Gilbert, Marissa, et al.
Publicado: (2022)

3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck – a multicentre, retrospective analysis
por: Helfenstein, Seth, et al.
Publicado: (2019)

Technical Advances and Pitfalls in Head and Neck Radiotherapy
por: Parvathaneni, Upendra, et al.
Publicado: (2012)

Defining the target for radiotherapy of head and neck cancer
por: Nuyts, S.
Publicado: (2007)

Current strategies in radiotherapy of head and neck cancer
por: Pütz, M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_9ahvmv6i6tubqgjjjup0c1bchl